IN THE NEWS

Newberry College

23December2025

Ritedose 2025 Year-In-Review

Ritedose’s 2025 Year-In-Review highlights a year of growth, innovation, and purpose-driven impact, advancing patient access through expanded generics, operational excellence, and community investment.

Ritedose 2025 Year-In-Review collage showcasing pharmaceutical manufacturing growth, community impact, respiratory medications, and Blow-Fill-Seal leadership.

21January2025

Ritedose and Newberry College Forge Strategic Partnership to Launch Pharmaceutical Manufacturing Program

COLUMBIA, S.C. Jan. 21, 2025 – In response to the growing demand for skilled professionals in South Carolina’s life sciences sector, The Ritedose Corporation has partnered with Newberry College to launch a new Pharmaceutical Manufacturing program, set to begin in…

Ritedose launch a pharmaceutical program

FEATURED NEWS

24th September 2025

Leading CDMO Enhances cGMP Lab Infrastructure to Strengthen Position

male scientist mixing chemicals in lab with text overlay "$17M expansion"

16th September 2025

How Blow-Fill-Seal Technology Ensures Sterile Medication Delivery

18th June 2025

Ritedose Unveils State-of-the-Art Distribution and Logistics Facility at Ritedose Performance Park

Stakeholders open the Ritedose distribution and logistics facility at Performance Park. L–R: Brian Taylor, VP Business Development, Miller Valentine Construction Jeff Ruble, Director, Richland County Economic Development Ashely Teasdel, Deputy Secretary, SC Dept. of Commerce Jody Chastain, CEO, Ritedose Jesica Mackey, Richland County Council District 9 Daniel Rickenmann, Mayor, City of Columbia Ronald Rhames, Fmr. President, Midlands Technical College Greg Little, President, Midlands Technical College

15th April 2025

Ritedose Adds Seventh Syntegon Packaging Line to Expand Single Vial Packaging Capabilities, Support Production of new COPD Drug Ohtuvayre

16th September 2024

Ritedose is Proud to Partner with Verona Pharma to Deliver First-In-Class COPD Drug, Ohtuvayre (ensifentrine)*

11th July 2024

Ritedose, the Leading Pharmaceutical Manufacturer (CDMO) Specializing in Sterile Blow-Fill-Seal, Expands its BFS Capacity to Meet the Growing Demand f…

18th January 2022

The Ritedose Corporation Announces Revolutionary Liquid Med Dispenser SuredoseRx™ to launch in first quarter

4th January 2022

Novo Holdings to acquire Ritedose

3rd August 2021

Ritedose Efficiency Innovation Yields Up to 25% Increase in CDMO Production Capability

RECEIVE THE LATEST NEWS

Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.

TAGS CLOUD